Bir grup şizofreni hastasında prodromal evrede risk belirteçlerinin retrospektif değerlendirilmesi

Year 2016, Volume: 41 Issue: 3, 437 - 446, 30.09.2016

Soner Çakmak , Mahmut Onur Karaytuğ Ufuk Bal Lut Tamam , Ali Taşdemir

https://doi.org/10.17826/cukmedj.234960

Cited By: 2

Abstract

Amaç: Bu çalışmanın amacı şizofreni hastalarında prodromal evrede risk belirleyicilerin şizofreni gelişiminde anlamlılığını ve bu belirleyicilerin şiddeti ile şizofreni gelişme süresi arasındaki bağıntıyı araştırmaktır.

Gereç ve Yöntem: Çalışmaya şizofreni tanısı almış olan, 18 yaş üstü hastalar dahil edilmiştir. Şizofreni prodromal evre risk belirleyicisi olarak SOPS (Prodromal Sendromlar Ölçeği) uygulanmış, ölçek puanları hesaplanmış ve hastaların SIPS (Prodromal Sendromlar İçin Yapılandırılmış Görüşme)’e göre adlandırılan risk sendromları ölçütlerine göre sınıflandırması yapılmıştır. Bulgular: Yüz hastanın 68’inde prodromal belirtiler saptanmıştır. 68 hastanın 47’si SIPS Hafif Pozitif Prodromal Sendrom (APPS), 20’si Kısa Aralıklı Psikotik Belirti Sendromu (BIPS), 24’ü Genetik Risk ve Yüksek Klinik Risk Kötüleşmesi (GRDS), 67’si Psikotik Sendrom (PS), 44’ü DSM-5 HPS ölçütlerini karşılamıştır. SOPS ölçek belirtilerinin anlamlılığına bakılmıştır. Ölçek belirtilerinden grandiozite, algısal anormallikler/varsanılar, düşünce fakirliği, bir rolün işlevinde kötüleşme, garip davranış ve görünüm, normal strese azalmış tolerans’ın APPS, BIPS ve DSM-5 HPS risk gruplarında anlamlı olarak bulunmuştur. 

Sonuç: Prodromal belirtilerin psikoz ve şizofreni gelişme olasılığını normal populasyona göre belirgin oranda artırdığı açıktır. Ancak riskin belirleyici ölçütlerin daha özelleştirilmesi ve ayrıntılandırılması, ölçütlerde nörobiyolojik risk faktörlerinin de araştırılarak ortaya konulması risk gruplarının daha güvenilir şekilde belirlenmesine ve prodromal dönemde hastalığın tanınmasına yardımcı olacaktır

Keywords

Şizofreni, prodrom, risk sendromları

Retrospective evaluation of risk determinants in prodromal period with a group of schizophrenia patients

Abstract

Purpose: This study aims to investigate the significance of risk determiners in the occurence of schizophrenia. and the link between the severity of determiners and the duration to full-blown schizophrenia.

Material and Methods: Patients older than 18 years old, diagnosed with schizophrenia are included in our study. SOPS (Scale of Prodromal Symptoms) is applied to determine the risk of schizophrenia prodromal period, scale scores are calculated and patients are classified in accordance to risk syndrome criteria defined in SIPS (Structured Interview for Prodromal Symptoms). 

Results: Prodromal symptoms are detected in 68 of 100 patients. Of those 68 patients, 47 met the criteria for Attenuated Positive Prodromal Syndrome (APPS), 20 met the criteria for Brief Intermittent Psychotic Syndrome (BIPS), 24 met the criteria for Genetic Risk and Deterioration Syndrome (GRDS), 67 met the criteria for Psychotic Syndrome (PS), 44 met the criteria for Attenuated Psychosis Syndrome (APS) in DSM-5. Grandiosity, perceptual abnormalities/hallucinations, poverty of thought, deterioration in a role functioning, peculiar behaviour and appearance, decreased tolerance to normal stress are manifested to be meaningful in APPS, Conclusion: It’s clear that prodromal symptoms are increasing markedly the odds of psychosis and schizophrenia occurance in respect to normal population. Nevertheless, further customization and elaboration of risk determining criteria, searching and displaying neurobiological risk factors among criteria, will help to reliably identify risk groups and detect disorder in prodromal period.

Keywords

Schizophrenia, prodrome, risk syndromes

References

• Tandon R, Keshavan MS, Nasrallah HA. Schizophrenia, ‘just the facts’: what we know in 2008. part 1: overview. Schizophr Res. 2008;100:4- 19.
• Tandon R, Nasrallah HA, Keshavan MS. Schizophrenia, ‘just the facts’ 4. clinical features and conceptualization. Schizophr Res. 2009;110:1-23.
• Gittelmqn-Klein R, Klein DF. Premorbid asocial adjustment and prognosis in schizophrenia. J Psychiatr Res. 1969;7:35-53.
• Harrow M, Tucker GJ, Bromet E. Short-term prognosis of schizophrenic patients. Arch Gen Psychitry. 1969;21:195-202.
• Bleuler M. The Schizophrenic Disorders: Long-Term Patient And Family Studies. New Haven, CT, Yale University Press. 1978.
• Evans Jr, Goldstein MJ, Rodnick EH. Premorbid adjustment, paranoid diagnosis, and remission: acute schizophrenics treated in a community mental health center. Arch Gen Psychiatry. 1973;28:666-72.
• Bromet E, Harrow M, Kasi S. Premorbid functioning and outcome in shizophrenics and non- schizophrenics. Arch Gen Psychiatry. 1974;30:203-7.
• Strauss JS, Carpenter WT. The prediction of outcome in schizophrenia. I. relationships between predictor and outcome variables: a report from the WHO international pilot study of schizophrenia. Arch Gen Psychiatry. 1974;31:37-42.
• Strauss JS, Carpenter WT. Prediction of outcome in schizophrenia: III. five year outcome and it’s predictors. Arch Gen Psychiatry. 1977;34:159-63.
• Bland RC, Orn H. 14-year outcome in early schizophrenia. Acta Psychiatr Scand. 1978;58:327-38.
• Fenton WS, McGlashan TH. Prognostic scale for chronic schizophrenia. Schizophr Bull. 1987;13:277- 84.
• McGorry PD, Nelson B, Amminger GP, Bechdolf A, Francey SM, Berger G et al. Intervention in individuals at ultra-high risk for psychosis: a review and future directions. J Clin Psychiatry 2009;70:1206- 12.
• Sullivan SH. The onset of schizophrenia. Am J Psychiatry. 1927;6:105-34.
• Gross G, Huber G, Klosterkotter J, Linz M. Bonn Scale for the Assessment of Basic Symptoms. Berlin, Germany, Springer, 1987.
• Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell’Olio M et al. Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Aust N Z J Psychiatry. 2005;39:964-71.
• Miller TJ, McGlashan TH, Rosen JL, Cadenhead K, Cannon T, Ventura J et al. Prodromal assessment with the structured interview for prodromal syndromes and scale of prodromal symptoms: predictive validity, inter-rater reliability and training to reliability. Schizophr Bull. 2003;29:703-15.
• Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane CA, Hallgren M et al. Psychosis prediction: 12-month follow-up of a high- risk(prodromal) group. Schizophr Res. 2003;60:21- 32.
• Schlosser DA, Jacobson S, Chen Q, Sugar CA, Niendam TA, Li G et al. Recovery from at-risk state: clinical and functional outcomes of putatively prodromal youth who do not develop psychosis. Schizophr Bull. 2012;38:1225-33.
• CannonTD, Cadenhead K, Cornblatt B, Woods SW, Addington J, Walker E et al. Prediction of psychosis in youth at high clinical risk: a multisite longitudinalstudy in North America. Arch Gen Psychiatry. 2008;65:28-37.
• Miller TJ., McGlashan TH., Woods SW., Stein K., Driesen N, Corcoran CM et al. Symptom assessment in schizophrenic prodromal states. Psychiatr Q. 1999;70:273-87.
• Woods SW., Addington J, Cadenhead KS., Cannon, TD., Cornblatt BA., Heinssen R et al. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr Bull. 2009;35:894-908.
• Pearson R, Stuart B, Loewy R. The assessment of attenuated psychotic symptoms in adolescents: concepts, practical approaches and prediction of risk. UC San Francisco Previously Published Works, 2012.
• Miller TJ, McQlashan TH, Rosen JL, Cadenhead K, Ventura J, McFarlane W et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull. 2003;29:703-15.
• Carpenter WT. Anticipating DSM-V: should psychosis risk become a diagnostic class? Schizophr Bull. 2009;35:841-43.
• Carpenter WT, van Os J. Should attenuated psychosis syndrome be a DSM-V diagnosis? Am J Psychiatry. 2011;168:460-3.
• American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 5th Edition. Washington, DC, American Psychiatric Association, 2013.
• Yung AR, Stanford C, Cosgrave E, Killackey E, Philips L, Nelson B et al. Testing the Ultra High Risk (prodromal criteria for the prediction of psychosis in a clinical sample of young people. Schizophr Res. 2006;84:57-66.
• Hafner H, van der Heiden W. Epidemology of schizophrenia. Can J Psychiatry 1997;42:139-51.
• Fusar-Poli P, Bonoldi I, Yung AR, Borgwardt S, Kempton MJ, Valmaggia L et al. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry. 2012;69:220–9.
• Werbeloff N, Drukker M, Dohrenwend BP, Levav I, Yoffe R, van Os J et al. Self-reported attenuated psychotic symptoms as forerunners of severe mental disorders later in life. Arch Gen Psychiatry. 2012;69:467–75.
• Cannon TD, Cadenhead K, Cornblatt B, Woods SW, Addington J, Walker E et al. Prediction of psychosis in youth at high clinical risk: a multisite longitudinalstudy in North America. Arch Gen Psychiatry. 2008;65:28-37.
• Woods SW, Addington J, Cadenhead KS, Cannon TD, Cormblatt BA, Heinssen R et al. Validity of the prodromal risk syndrome for first psychosis: findings from the North American prodrome longitudinal study. Schizophr Bull. 2009;35:894-908.
• Corcoran CM, First MB, Cornblatt B. The psychosis- risk syndrome and its proposed inclusion in the DSM-V. A risk-benefit analysis. Schizophr Res. 2010;120:16-22.